Latest other assets for ITOS: $-1K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2025), ITOS shows a other assets of $-1K. That compares with $1 in the prior-year period — down 100100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ITOS's other assets is now $-1K (was $1) — a 100100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ITeos Therapeutics is outperforming or lagging.
Tracking ITOS's other assets over time shows whether ITeos Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-1K That compares with $1 in the prior-year period — down 100100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other assets page, Stockcircle has ITeos Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $-1K) with ownership activity and broader fundamentals.
ITeos Therapeutics's other assets is $-1K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.